FDA Inspection 830255 — Merckle GmbH
The FDA completed an inspection of Merckle GmbH on Apr 25, 2013 in Ulm. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 25, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ulm (Germany)
Additional details
Sponsor, Contract Research Organization